205 related articles for article (PubMed ID: 35074329)
1. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.
Zou X; Tang XY; Qu ZY; Sun ZW; Ji CF; Li YJ; Guo SD
Int J Biol Macromol; 2022 Mar; 202():539-557. PubMed ID: 35074329
[TBL] [Abstract][Full Text] [Related]
2. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies.
Pandey P; Khan F; Upadhyay TK; Seungjoon M; Park MN; Kim B
Biomed Pharmacother; 2023 May; 161():114491. PubMed ID: 37002577
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
4. Abundance of platelet-derived growth factors (PDGFs), PDGF receptors and activation of mitogen-activated protein kinases in brain decline with age.
Hu Y; Schett G; Zou Y; Dietrich H; Xu Q
Brain Res Mol Brain Res; 1998 Jan; 53(1-2):252-9. PubMed ID: 9473686
[TBL] [Abstract][Full Text] [Related]
5. PDGFs and their receptors.
Kazlauskas A
Gene; 2017 May; 614():1-7. PubMed ID: 28267575
[TBL] [Abstract][Full Text] [Related]
6. The PDGF/PDGFR pathway as a drug target.
Papadopoulos N; Lennartsson J
Mol Aspects Med; 2018 Aug; 62():75-88. PubMed ID: 29137923
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation.
Yu J; Deuel TF; Kim HR
J Biol Chem; 2000 Jun; 275(25):19076-82. PubMed ID: 10777515
[TBL] [Abstract][Full Text] [Related]
8. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis.
Cao Y
Trends Mol Med; 2013 Aug; 19(8):460-73. PubMed ID: 23773831
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor (PDGF) receptor-alpha-activated c-Jun NH2-terminal kinase-1 is critical for PDGF-induced p21WAF1/CIP1 promoter activity independent of p53.
Yu J; Liu XW; Kim HR
J Biol Chem; 2003 Dec; 278(49):49582-8. PubMed ID: 14506245
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.
Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y
Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor/platelet-derived growth factor (PDGFR/PDGF) system is a prognostic and treatment response biomarker with multifarious therapeutic targets in cancers.
Appiah-Kubi K; Wang Y; Qian H; Wu M; Yao X; Wu Y; Chen Y
Tumour Biol; 2016 Aug; 37(8):10053-66. PubMed ID: 27193823
[TBL] [Abstract][Full Text] [Related]
13. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
Roskoski R
Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
[TBL] [Abstract][Full Text] [Related]
14. Sennoside B inhibits PDGF receptor signaling and cell proliferation induced by PDGF-BB in human osteosarcoma cells.
Chen YC; Chang CN; Hsu HC; Chiou SJ; Lee LT; Hseu TH
Life Sci; 2009 Jun; 84(25-26):915-22. PubMed ID: 19393247
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
[TBL] [Abstract][Full Text] [Related]
16. Research progress on the role of PDGF/PDGFR in type 2 diabetes.
Cao Z; Liu Y; Wang Y; Leng P
Biomed Pharmacother; 2023 Aug; 164():114983. PubMed ID: 37290188
[TBL] [Abstract][Full Text] [Related]
17. The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer.
Wang Y; Appiah-Kubi K; Wu M; Yao X; Qian H; Wu Y; Chen Y
Growth Factors; 2016 Feb; 34(1-2):64-71. PubMed ID: 27170215
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction proteins that associate with the platelet-derived growth factor (PDGF) receptor mediate the PDGF-induced release of glucose-6-phosphate dehydrogenase from permeabilized cells.
Tian WN; Pignatare JN; Stanton RC
J Biol Chem; 1994 May; 269(20):14798-805. PubMed ID: 8182086
[TBL] [Abstract][Full Text] [Related]
19. The Role of PDGFs and PDGFRs in Colorectal Cancer.
Manzat Saplacan RM; Balacescu L; Gherman C; Chira RI; Craiu A; Mircea PA; Lisencu C; Balacescu O
Mediators Inflamm; 2017; 2017():4708076. PubMed ID: 28163397
[No Abstract] [Full Text] [Related]
20. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]